Formulation of non-sterile
drug products; solids,
semi-solids and liquids
Excipient compatibility
studies
Excipient selection
and ratio determination
Immediate release dosage
form development
Modified and sustained
release dosage form
development
Brand extension formulation
development
Dosage form specification
development
Blending, drying, granulation
and coating development
Manufacturing process
optimization
Drug product specification
development
Protein and peptide
liquid formulation
Schedule II - IV drug
product development
DEA Approved
Dissolution
testing
Stability testing
Purity testing
Impurity identification
Particle size determination
Compatibility testing
Solubility screening
Hygroscopicity studies
Bio-analytic methods
development and validation
Methods qualification
and validation
Protein and peptide
based characterization
Chromatography and electrophoresis
Controlled drug substances
testing (C II - C V)
Clinical Manufacturing
cGMP manufacturing through
phase I, II & III
Dosage form preparation
and blinding
Open and blinded clinical
packaging and labeling
Semi-automated overencapsulation
Granulation, tableting,
encapsulation and coating
Schedule II - V control
drug manufacturing
Biotechnology Services
Protein preformulation
and formulation development
ICH compliant stability
studies
Protein characterization
- chromatographic and
electrophoresis separation,
peptide mapping, isoelectric(IEF)
focusing, SDS Page,
Western blot and amino
acid analysis
Bioanalytical methods
development and validation
Methods qualification
and validation
cGMP release
Regulatory Support
SUPAC applications
ICH interpretations
Chemistry, manufacturing
and control section
preparation for IND,
NDA,ANDA submissions
Product development
strategies